Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of26M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States26M100.00%